RNA-Based Vaccines and Therapeutics
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Gene and Cell Therapy".
Deadline for manuscript submissions: closed (31 October 2024) | Viewed by 268
Special Issue Editors
Interests: vaccine development; mRNA vaccines; nucleic acid-based therapeutics; public health
Interests: cellular immunology; humoral immunology; vaccinology; innovation; RNA vaccines; RNA therapeutics; vaccine equity and access
Interests: nanotechnology; protein structure and function; vaccinology; RNA vaccines; RNA therapeutics
Special Issue Information
Dear Colleagues,
This Special Issue aims to explore the groundbreaking innovations and recent advancements made in RNA-based vaccines and therapeutics, as well as their implications for global health equity. RNA technology has garnered significant attention in recent years, particularly with the emergence of RNA COVID-19 vaccines. This Special Issue delves into the underlying science, development processes, and clinical applications of RNA-based interventions across various disease areas. From elucidating the fundamental principles of RNA biology to discussing the challenges and opportunities in vaccine design and delivery, this collection of articles will offer insights from leading experts in the field. Furthermore, this Special Issue will explore the potential of RNA therapeutics beyond infectious diseases, including their application in cancer immunotherapy, genetic disorders, and regenerative medicine. Through comprehensive reviews, original research articles, and perspectives, this Special Issue aims to provide a comprehensive overview of the current state of the art and future directions in RNA-based vaccines and therapeutics.
We look forward to receiving your contributions.
Dr. Sotiris Missailidis
Dr. Patrícia Cristina Da Costa Neves
Dr. Ana Paula Dinis Ano Bom
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- RNA vaccines
- RNA therapeutics
- delivery systems
- analytical and process development
- global health implications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
